Topo-guided LASIK and Photorefractive Keratectomy vs Wavefront LASIK and Photorefractive Keratectomy

NCT ID: NCT03075176

Last Updated: 2023-07-17

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

39 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-02-13

Study Completion Date

2019-08-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates the difference in results between eyes that have been treated wavefront optimized laser vision correction (either LASIK or Photorefractive Keratectomy) compared to eyes treated with topography-guided laser vision correction (either LASIK or Photorefractive Keratectomy). Each participant will receive wavefront optimized correction in one eye and topography-guided correction in the other.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants will have an in depth discussion with our refractive surgery coordinator regarding refractive surgery. Patients will choose LASIK or Photorefractive Keratectomy surgery based on our standard pre-operative discussion that is provided to all patients. As is standard for laser refractive candidates, the advantages and disadvantages of LASIK and Photorefractive Keratectomy compared to the other refractive surgical options will be discussed. Following patient selection of their preferred type of refractive procedure they will be randomized as discussed below, and only patients who elect for LASIK or Photorefractive Keratectomy will be included in our study.

Prior to surgery, one eye from each patient will be randomly assigned to receive either Wavefront optimized or Topography Guided treatment. Each patient in the study will have a fellow eye enrolled in the other treatment group. Patients will either receive LASIK treatment or Photorefractive Keratectomy treatment in both eyes but the eyes will be randomized to topography guided or wavefront optimized forms of treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Surgery Myopia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Each participant will receive wavefront optimized surgery in one eye and topography-guided surgery in the second eye.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants
Participants will be masked as to which type of surgery they receive in either eye.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Wavefront optimized LASIK

Participants who chose to have LASIK surgery were assigned to have Wavefront optimized LASIK in one eye and Topography-guided LASIK in the other eye (randomly chosen).

Group Type ACTIVE_COMPARATOR

Wavefront optimized LASIK

Intervention Type DEVICE

Wavefront optimized laser vision correction

Topography-guided LASIK

Intervention Type DEVICE

Topography-guided laser vision correction

Wavefront optimized Photorefractive Keratectomy

Participants who chose to have Photorefractive Keratectomy surgery were assigned to have Wavefront optimized Photorefractive Keratectomy in one eye and Topography-guided Photorefractive Keratectomy in the other eye (randomly chosen).

Group Type ACTIVE_COMPARATOR

Wavefront optimized Photorefractive Keratectomy

Intervention Type DEVICE

Wavefront optimized laser vision correction

Topography-guided Photorefractive Keratectomy

Intervention Type DEVICE

Topography-guided laser vision correction

Topography-guided LASIK

Participants who chose to have LASIK surgery were assigned to have Topography-guided LASIK in one eye and Wavefront optimized LASIK in the other eye (randomly chosen).

Group Type ACTIVE_COMPARATOR

Wavefront optimized LASIK

Intervention Type DEVICE

Wavefront optimized laser vision correction

Topography-guided LASIK

Intervention Type DEVICE

Topography-guided laser vision correction

Topography-guided Photorefractive Keratectomy

Participants who chose to have Photorefractive Keratectomy surgery were assigned to have Topography-guided Photorefractive Keratectomy in one eye and Wavefront optimized Photorefractive Keratectomy in the other eye (randomly chosen).

Group Type ACTIVE_COMPARATOR

Wavefront optimized Photorefractive Keratectomy

Intervention Type DEVICE

Wavefront optimized laser vision correction

Topography-guided Photorefractive Keratectomy

Intervention Type DEVICE

Topography-guided laser vision correction

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Wavefront optimized LASIK

Wavefront optimized laser vision correction

Intervention Type DEVICE

Wavefront optimized Photorefractive Keratectomy

Wavefront optimized laser vision correction

Intervention Type DEVICE

Topography-guided LASIK

Topography-guided laser vision correction

Intervention Type DEVICE

Topography-guided Photorefractive Keratectomy

Topography-guided laser vision correction

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All subjects who are deemed suitable candidates for laser refractive surgery after routine refractive surgery screening will be considered eligible for participation in this study.

Subjects must be at least 21 years of age and not pregnant or nursing (due to fluctuations in visual parameters during pregnancy)

Exclusion Criteria

* Any patient who is not a suitable candidate for LASIK or PRK will not be included.
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Utah

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mark Mifflin

Professor, Ophthalmology/Visual Sciences

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mark Mifflin, MD

Role: PRINCIPAL_INVESTIGATOR

University of Utah Moran Eye Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Moran Eye Center - Midvalley Location

Murray, Utah, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB # 95434

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Topography-guided LASIK Surgery
NCT03292419 COMPLETED NA
Comparison of LASIK and SBK
NCT00714363 COMPLETED NA